Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018409369> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2018409369 endingPage "66" @default.
- W2018409369 startingPage "55" @default.
- W2018409369 abstract "High plasma levels of LDL cholesterol, triglycerides and low levels of HDL cholesterol are strong and independent risk factors of coronary heart disease (CHD). The first two abnormalities are addressed by a variety of drugs including statins, cholesterol absorption inhibitors, fibrates and niacin. Some of these drugs also elevate HDL albeit weakly. Thus treatments optimized for HDL elevation are still an unmet medical need. Low HDL-C is the most common lipoprotein abnormality in patients with CHD and the body of evidence showing an inverse relationship between HDL-C levels and risk for CHD has grown large. Research in the past decade not only greatly enhanced our understanding of HDL metabolism but also offered potential therapeutic targets to address low HDL syndrome. There are two classes of these ‘HDL drugs’ - those that elevate plasma HDL (e.g. cholesteryl ester transfer protein - CETP and ligands of transcription factors such as peroxisome proliferator activated receptor PPAR α/δ, liver X receptor (LXR)) and those that mimic HDL and facilitate reverse cholesterol transport (RCT) a key function of plasma HDL. HDL mimetics, which include ApoA1 mutants and peptide mimetics of ApoA1, are thought to be ‘fast acting’ and may show greater benefits especially in acute coronary syndromes. The purpose of this review is to examine key players in HDL metabolism and therapeutics that modulate/ mimic these targets. The prospect of these approaches in the prevention of cardiovascular disease is also discussed. Keywords: coronary heart disease (CHD), reverse cholesterol transport (RCT), VLDL, apoA-I, peroxisome proliferator-activated receptors, LXR-Ligands" @default.
- W2018409369 created "2016-06-24" @default.
- W2018409369 creator A5025548638 @default.
- W2018409369 creator A5041372158 @default.
- W2018409369 date "2007-01-01" @default.
- W2018409369 modified "2023-09-25" @default.
- W2018409369 title "HDL Elevators and Mimetics - Emerging Therapies for Atherosclerosis" @default.
- W2018409369 doi "https://doi.org/10.2174/187152507779315796" @default.
- W2018409369 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17266548" @default.
- W2018409369 hasPublicationYear "2007" @default.
- W2018409369 type Work @default.
- W2018409369 sameAs 2018409369 @default.
- W2018409369 citedByCount "30" @default.
- W2018409369 countsByYear W20184093692012 @default.
- W2018409369 countsByYear W20184093692013 @default.
- W2018409369 countsByYear W20184093692023 @default.
- W2018409369 crossrefType "journal-article" @default.
- W2018409369 hasAuthorship W2018409369A5025548638 @default.
- W2018409369 hasAuthorship W2018409369A5041372158 @default.
- W2018409369 hasConcept C104317684 @default.
- W2018409369 hasConcept C110459506 @default.
- W2018409369 hasConcept C126322002 @default.
- W2018409369 hasConcept C134018914 @default.
- W2018409369 hasConcept C167400880 @default.
- W2018409369 hasConcept C185592680 @default.
- W2018409369 hasConcept C2778163477 @default.
- W2018409369 hasConcept C2778657065 @default.
- W2018409369 hasConcept C2780072125 @default.
- W2018409369 hasConcept C2780092750 @default.
- W2018409369 hasConcept C45505151 @default.
- W2018409369 hasConcept C55493867 @default.
- W2018409369 hasConcept C60644358 @default.
- W2018409369 hasConcept C63932345 @default.
- W2018409369 hasConcept C71924100 @default.
- W2018409369 hasConcept C86339819 @default.
- W2018409369 hasConcept C86803240 @default.
- W2018409369 hasConcept C98274493 @default.
- W2018409369 hasConceptScore W2018409369C104317684 @default.
- W2018409369 hasConceptScore W2018409369C110459506 @default.
- W2018409369 hasConceptScore W2018409369C126322002 @default.
- W2018409369 hasConceptScore W2018409369C134018914 @default.
- W2018409369 hasConceptScore W2018409369C167400880 @default.
- W2018409369 hasConceptScore W2018409369C185592680 @default.
- W2018409369 hasConceptScore W2018409369C2778163477 @default.
- W2018409369 hasConceptScore W2018409369C2778657065 @default.
- W2018409369 hasConceptScore W2018409369C2780072125 @default.
- W2018409369 hasConceptScore W2018409369C2780092750 @default.
- W2018409369 hasConceptScore W2018409369C45505151 @default.
- W2018409369 hasConceptScore W2018409369C55493867 @default.
- W2018409369 hasConceptScore W2018409369C60644358 @default.
- W2018409369 hasConceptScore W2018409369C63932345 @default.
- W2018409369 hasConceptScore W2018409369C71924100 @default.
- W2018409369 hasConceptScore W2018409369C86339819 @default.
- W2018409369 hasConceptScore W2018409369C86803240 @default.
- W2018409369 hasConceptScore W2018409369C98274493 @default.
- W2018409369 hasIssue "1" @default.
- W2018409369 hasLocation W20184093691 @default.
- W2018409369 hasLocation W20184093692 @default.
- W2018409369 hasOpenAccess W2018409369 @default.
- W2018409369 hasPrimaryLocation W20184093691 @default.
- W2018409369 hasRelatedWork W1936109784 @default.
- W2018409369 hasRelatedWork W1981269392 @default.
- W2018409369 hasRelatedWork W1998164142 @default.
- W2018409369 hasRelatedWork W2017088706 @default.
- W2018409369 hasRelatedWork W2018409369 @default.
- W2018409369 hasRelatedWork W2076636344 @default.
- W2018409369 hasRelatedWork W2271298233 @default.
- W2018409369 hasRelatedWork W2405981240 @default.
- W2018409369 hasRelatedWork W3036866 @default.
- W2018409369 hasRelatedWork W42857451 @default.
- W2018409369 hasVolume "5" @default.
- W2018409369 isParatext "false" @default.
- W2018409369 isRetracted "false" @default.
- W2018409369 magId "2018409369" @default.
- W2018409369 workType "article" @default.